Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
AJNR. American Journal of Neuroradiology|February 23, 2026
[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response BiomarkerKellen Vo Vu, Hannah G Otis, Andrew Brandmaier, et al.
Neuro-Oncology|March 30, 2024
[Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomasJana Ivanidze, Se Jung Chang, Arsalan Haghdel, et al.
AJNR. American Journal of Neuroradiology|April 11, 2024
DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 MeningiomasJoon Tae Kim, Se Jung Chris Chang, Arsalan Haghdel, et al.
European Journal of Radiology|October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastasesJana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
Neuro-Oncology Advances|January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningiomaJana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
Nature Medicine|January 16, 2026
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trialPriscilla K Brastianos, Katharine Dooley, Susan Geyer, et al.
AJNR. American Journal of Neuroradiology|December 1, 2025
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with GlioblastomaJana Ivanidze, Kellen Vo Vu, Rongwei Fu, et al.
Pageof 3